全国人民代表大会关于修改《中华人民共和国立法法》的决定
Decision of the National People's Congress on Amending the Legislation Law of the People's Republic of China
中华人民共和国主席令 第三号
Order of the President of the People's Republic of China No. 3
《全国人民代表大会关于修改〈中华人民共和国立法法〉的决定》已由中华人民共和国第十四届全国人民代表大会第一次会议于2023年3月13日通过，现予公布，自2023年3月15日起施行。
The Decision of the National People's Congress on Amending the Legislation Law of the People's Republic of China, as adopted at the 1st session of the 14th National People's Congress of the People's Republic of China on March 13, 2023, is hereby promulgated and shall come into effect on March 15, 2023.
中华人民共和国主席 习近平
XI Jinping, President of the People's Republic of China
2023年3月13日
March 13, 2023
全国人民代表大会关于修改《中华人民共和国立法法》的决定
Decision of the National People's Congress on Amending the Legislation Law of the People's Republic of China
（2023年3月13日第十四届全国人民代表大会第一次会议通过）
(Adopted at the 1st session of the 14th National People's Congress on March 13, 2023)
第十四届全国人民代表大会第一次会议决定对《中华人民共和国立法法》作如下修改：
At the 1st session of the 14th National People's Congress, it has been decided to make the following amendments to the Legislation Law of the People's Republic of China:
详情请参阅：全国人民代表大会关于修改《中华人民共和国立法法》的决定
For more details, please refer to: Decision of the National People's Congress on Amending the Legislation Law of the People's Republic of China
中华人民共和国立法法全文：中华人民共和国立法法
Full text of the Legislation Law of the People's Republic of China: Legislation Law of the People's Republic of China
（来源：新华网）
(Source: news.cn)
尼斯分类NCL12-2023文本中日韩商品和服务类似群编码对照表
Nice NCL12-2023 Classification Table for China-Japan-South Korea Trademark Applicants
根据中日韩商标领域合作安排，为进一步便利申请人，现发布尼斯分类NCL12-2023文本中日韩商品和服务类似群编码对照表。
Per the arrangement among China, Japan and South Korea for the cooperation in the field of trademark protection, the correspondence table of codes for China-Japan-South Korea similar groups of goods and services under code of the Nice Classification NCL12-2023 is hereby announced.
附件：尼斯分类NCL12-2023文本中日韩商品和服务类似群编码对照表.xlsx
Attachment: Nice NCL12-2023 Classification Table.xlsx
（来源：中国国家知识产权局商标局）
(Source: Trademark Office of China National Intellectual Property Administration)
中国首个量子计算专利池在京成立
China's First Quantum Computing Patent Pool Established in Beijing
近日，以“知产协同创新 共筑量子未来”为主题的量子计算产业知识产权联盟暨量子计算专利池成立大会在京召开。会上，百度联合北京量子信息科学研究院，宣布成立“量子计算专利池”，为中国量子知识产权发展构建坚固“护城河”。
Recently, the Quantum Computing Industry Intellectual Property Alliance & the Quantum Computing Patent Pool Establishment Conference themed on "Collaborative Innovation of Intellectual Property to Build a Quantum Future Together" was held in Beijing. At the conference, Baidu, in conjunction with the Beijing Academy of Quantum Information Sciences, announced the establishment of the "Quantum Computing Patent Pool", with the aim of constructing a sturdy "fortress" for the development of quantum intellectual property in China.
目前，该专利池已聚集几十件量子专利，面向联盟成员开放共享，将为联盟成员搭建合作桥梁，从而推动量子产业行业标准的制订与标准必要专利的布局。同时，联盟成员可通过专利池统一发声，构建有利于量子计算产业健康发展的知识产权环境。后续，专利池将重点布局量子测控、量子安全与加密、量子架构与软件、量子纠错、量子算法与应用等7大量子产业领域。
Currently, the patent pool has agglomerated dozens of quantum patents and is open to and shared by alliance members and will create a cooperation bridge for alliance members to promote the formulation of industrial criteria for the quantum industry and the layout of standards-essential patents. Meanwhile, the alliance members can utter a unified voice through the patent pool to create an intellectual property environment favorable to the healthy development of quantum computing industry. In the subsequent period, the patent pool will focus on the collaboration among seven primer quantum industry fields, including quantum measurement and control, quantum security and encryption, quantum architecture and software, quantum error correction, and quantum algorithm and application.
据悉，北京地区量子产业化创新主体在量子领域的发明专利申请量位居全国首位，而联盟成员在量子领域的发明专利申请总量在北京占比达70%。作为专注于量子知识产权领域的联盟组织，联盟将推动量子领域高价值专利培育、专利交叉授权许可、创新主体向行业标准靠拢等，并向关键量子专利领域布局，牵引整个量子产业高效发展。
It is reported that, the quantum industrialization innovation subjects in Beijing region rank first in the country on the number of patent applications for invention in the quantum field, and the alliance members reach a proportion of up to 70% to the total number of patent applications for invention in the quantum field in Beijing. As an alliance organization focusing on the field of quantum intellectual property, the alliance will stimulate the ongoing compliance of the high value patent cultivation, the cross grant and licensing of patents, and the innovation subjects in the quantum field with industrial criteria or the like, and arrange layouts towards critical quantum patent fields, so as to dominate the efficient development of the entire quantum industry.
（来源：中国知识产权资讯网）
(Source: http://www.iprchn.com)
中欧亚专利审查高速路（PPH）试点项目延长
CNIPA-EAPO Patent Prosecution Highway (PPH) Pilot Program Extended
经中国国家知识产权局和欧亚专利局的共同决定，将自2023年4月1日起无限期延长中欧亚PPH试点项目。
Upon a joint decision by the China National Intellectual Property Administration (CNIPA) and the Eurasian Patent Organization (EAPO), the CNIPA-EAPO PPH pilot program will be extended for an indefinite time period, starting on April 1, 2023.
本次延长后的中欧亚PPH试点将在原有常规PPH合作的基础上增加PCT-PPH合作模式，双方申请人可以利用PCT国际阶段的工作结果向中欧亚两局提出PPH请求。参与本试点项目的要求和流程可以参考更新版的中欧亚PPH指南。
For the CNIPA-EAPO PPH pilot after the extension, the PCT-PPH cooperation mode will be added on the basis of the original conventional PPH cooperation. The applicants on both sides can take advantage of the work products in the PCT international phase to file PPH requests with the CNIPA or the EAPO. For the requirements for and procedures of participating in the present pilot program, reference can be made to the updated version of CNIPA-EAPO PPH Guidelines.
PPH是不同国家或地区间的专利快速审查通道，通过专利审查机构之间的工作共享加快专利审查进程。自2011年11月启动首项PPH试点至今，国家知识产权局已经先后与30个国家或地区的专利审查机构建立了PPH合作。
PPH is an expedited patent examination passageway between different countries or regions, which accelerates the patent examination process by virtue of shared work between patent examination organs. Since the launch of the first PPH pilot in November 2011, CNIPA has successively established PPH cooperation with patent examination organs in 30 countries or regions.
欧亚专利局覆盖欧亚地区多个国家，欧亚专利一经授权，自公告之日起在其缔约国内生效。中欧亚PPH试点项目延长将进一步促进“一带一路”沿线国家和地区知识产权合作，服务中欧亚创新主体加快专利审查进程。 （李韩泽）
The EAPO encompasses a plurality of countries in the Eurasian region. Upon the grant, the Eurasian patent enters into force in the signatory countries from the date of announcement. The extension of the CNIPA-EAPO PPH pilot program will further promote the intellectual property cooperation in countries and regions along the "Belt and Road” and serve the Chinese and Eurasian innovation subjects to accelerate the patent examination process. (LI Hanze)
相关链接：中国国家知识产权局与欧亚专利局PPH指南
Related Link: PPH Guidelines of China National Intellectual Property Administration and Eurasian Patent Organization
（来源：中国国家知识产权局网站）
(Source: website of CNIPA)
中挪（威）专利审查高速路（PPH）试点项目延长
CNIPA-NIPO Patent Prosecution Highway (PPH) Pilot Program Extended
经中国国家知识产权局和挪威工业产权局的共同决定，将中挪（威）PPH试点项目自2023年4月1日起延长五年，至2028年3月31日结束。参与本试点项目的要求和流程继续沿用中挪（威）PPH指南。
Upon a joint decision by the China National Intellectual Property Administration (CNIPA) and the Norwegian Industrial Property Office (NIPO), the CNIPA-NIPO PPH pilot program will be extended for five years effective from April 1, 2023 to March 31, 2028. The requirements for and procedures of participating in the present pilot program shall continue to follow the CNIPA-NIPO PPH Guidelines.
（来源：中国国家知识产权局网站）
(Source: website of CNIPA)
典型案例：
集佳代理11件外观设计专利无效案取得全面胜利
Unitalen Agency Achieved Overall Victory in Cases on Invalidation for 11 Design Patents
基本案情
Case Brief
此前，专利权人深圳某公司在与客户公司的诉讼纠纷中，提交了5件外观设计专利证据，并据此主张了巨额赔偿。客户公司遂委托集佳代理团队，从专利权稳定性入手反制对方，就对方包括前述5件专利在内的11件外观设计专利权向国家知识产权局提起无效宣告请求。
Previously, a company in Shenzhen as the patentee submitted the evidence for 5 design patents in a litigation dispute with the client company, and accordingly claimed a huge sum of compensation. Under the authorization by the client company, the Unitalen agency team, making breakthrough out of stability of patent rights, adopted countermeasures against the opponent by filing with the China National Intellectual Property Administration (CNIPA) a request for invalidation of 11 design patents held by the opponent, inclusive of the foregoing 5 patents.
涉案专利均为棉柔巾产品的外包装盒及外包装袋，具有相似的设计元素和设计风格。其中，10件专利的申请日为2017年6月5日，1件专利的申请日为2019年1月10日，所有专利均未对外观设计的颜色予以保护。
All the patents involved are outer packaging boxes and outer packaging bags of cotton soft tissue products, with similar design elements and design styles. In this regard, 10 patents have a filing date of June 5, 2017, and 1 patent has a filing date of January 10, 2019. None of the patents protects the color of the design.
集佳代理团队通过调查发现，专利权人的部分外观设计专利存在“使用在先，申请在后”的情况。同时，另一部分外观设计专利本质上属于简单设计特征的组合，不符合授予专利权的相关规定。为了确保无效宣告请求理由得到合议组的认可，集佳代理团队在已有证据的基础上对11件外观设计专利展开了全面、专业的外观设计专利无效检索，检索范围包括但不限于专利数据库、微博平台、抖音短视频平台、淘宝网、京东、苏宁易购、母婴论坛及其他第三方网站等。经过检索，团队获取了较为有利的现有设计证据，并及时进行了保全固定。然后团队通过反复讨论，慎重选定了各个专利的无效证据最佳组合方式，制定了各个案件具体的无效策略，为后续案件口审程序的顺利进行和最终无效程序的全面胜利奠定了基础。
After the survey, the Unitalen agency team discovered that parts of the design patents of the patentee involve the circumstance of "use before application". Moreover, the other parts of the design patents are essentially combinations of simple design features, failing to comply with applicable provisions on granting patent rights. In order to secure that the grounds of invalidation request are recognized by the collegiate panel, the Unitalen agency team, on the basis of existing evidence, carried out an all-round, technical search on design patent invalidation targeted at the 11 design patents. The search scope included, but was not limited to, patent database, Weibo platform, TikTok short video platform, Taobao, JD.COM, SUNING.COM, maternal and child forums, other third-party websites, etc. After the search, the team obtained more favorable prior design evidence and performed preservation and fixation in a timely manner. Afterwards, with proper deliberation, the team prudently selected the optimal combination modes of invalidation evidence for the respective patents, and formulated the specific invalidation strategies for the respective cases, laying the foundation for the successful enforcement of the subsequent oral proceedings of the cases and for the overall victory in the final invalidation proceedings.
亮点小结
Highlights Summary
在涉诉情况下通过无效宣告程序对权利人的权利提出挑战，是一项可选择的应对策略。在本案中，集佳专利团队针对权利人的诉讼证据仔细梳理，以系列设计特征“使用在先、申请在后”为关键线索，展开细致而全面的检索工作，在证据筛选和组合上也充分体现了代理人的专业性。
It is an alternative coping strategy to challenge the rights of rights-holders by invalidation proceedings in the case of litigation. In the present case, the Unitalen agency team closely checked the litigation evidence presented by the rights holder, and held the key clue, namely, "use before application" of sets of design features, to carry out meticulous and overall search. In addition, the agents embodied their proficiency in screening and combining evidence.
本案提醒外观设计专利申请人，一定要做好外观设计方案的保密工作，避免因在先公开披露或使用导致权利基础出现不稳定的情况。
From the present case, the applicant for design patent shall note that, it is necessary to keep design solutions in proper confidentiality, thereby avoiding the circumstance of instability in the basis of rights due to prior public disclosure or use.
中国首例药品专利链接诉讼案——中外制药株式会社与温州海鹤药业有限公司确认是否落入专利权保护范围纠纷案
China's First Litigation Case of Pharmaceutical Patent Linkage —— Chugai Pharmaceutical Co., Ltd. vs. Wenzhou Haihe Pharmaceutical Co., Ltd., Case of Dispute over Identifying Whether to Fall into Protection Scope of Patent Rights
基本案情
Case Brief
中外制药株式会社依据专利法第七十六条第一款向北京知识产权法院提起药品专利链接诉讼，请求确认温州海鹤公司的“艾地骨化醇软胶囊”仿制药技术方案落入涉案专利权利要求的保护范围。一审法院判决驳回中外株式会社的诉讼请求。中外制药株式会社不服，提起上诉。最高人民法院二审认为，温州海鹤公司未针对保护范围最大的权利要求作出声明，未将声明及声明依据及时通知上市许可持有人中外制药株式会社，其行为有所不当，应予批评；关于仿制药技术方案是否落入专利权利要求保护范围的判断，原则上应当以仿制药申请人的申报资料为依据比对评判；经比对，涉案仿制药技术方案未落入专利权利要求保护范围。遂判决驳回上诉，维持原判。
In light of Article 76.1 of the Chinese Patent Law, Chugai Pharmaceutical Co., Ltd. filed a lawsuit on pharmaceutical patent linkage with the Beijing Intellectual Property Court, requesting to identify that the technical solution of the generic drug "Eldecalcitol Soft Capsules" of Wenzhou Haihe falls into the protection scope of patent claims involved. The court of first instance ordered to reject the litigation claims filed by Chugai Co., Ltd. Chugai Pharmaceutical Co., Ltd. was dissatisfied and filed an appeal. The Supreme People's Court held in the second instance that, Wenzhou Haihe failed to make any statement on the claim with the maximum protection scope and to notify Chugai Pharmaceutical Co., Ltd., the marketing authorization holder, of the statement and the statement basis in a timely manner, and such failure was inappropriate and should be criticized; as for the determination of whether the technical solution of generic drug would fall into the protection scope of patent claims, in principle, comparison and evaluation should be conducted based on the application files submitted by the generic drug applicant; upon comparison, the technical solution of generic drug involved did not fall into the protection scope of patent claims. It was therefore ordered to reject the appeal and uphold the original sentence.
典型意义
Typical Significance
本案系中国首例药品专利链接诉讼案件。中国药品专利链接制度初建，尚处于探索阶段，本案判决对药品专利链接制度实践初期出现的新问题进行了符合立法目的的探索性法律适用，受到中外媒体和医药界的普遍关注和广泛好评。中央广播电视总台第一时间予以报道，入选“新时代推动法治进程2022年度十大提名案件”。
The present case is China's first litigation case of pharmaceutical patent linkage. China's pharmaceutical patent linkage system is preliminarily established and is still in the exploration phase. The judgment of the present case embodies legislative-purpose-compliant exploratory legal application regarding new issues incurred in the initial practice phase of pharmaceutical patent linkage system and receives considerable attention and widespread praise from the Chinese and foreign media and pharmaceutical communities. CMG has promptly reported the present case, which is selected as one of the "Top Ten Nomination Cases for Promoting the Process of Rule of Law in the New Era in 2022".
（案例来源：中华人民共和国最高人民法院）
(Source of case: Supreme People's Court of the People's Republic of China)
杂交玉米植物新品种亲本“W68”技术秘密侵权案——河北华穗种业有限公司与武威市搏盛种业有限责任公司侵害技术秘密纠纷案
Case of Infringement on Technical Secrets of Parent "W68" of New Variety of Hybrid Maize Plant —— Hebei Huasui Seed Industry Co., Ltd. vs. Wuwei City Bosheng Seed Industry Co., Ltd., Case of Dispute over Infringement on Technical Secrets
基本案情
Case Brief
华穗种业公司是“万糯2000”玉米植物新品种的品种权人，同时主张其系“万糯2000”的亲本“W68”的技术秘密权利人。华穗种业公司起诉搏盛种业公司侵害“W68”的技术秘密，请求判令其承担有关侵权责任。
Huasui Seed Industry was the variety rights holder of "Wannuo 2000", a new variety of maize plant, and alleged to be the rights holder of technical secrets of parent "W68" of "Wannuo 2000". Huasui Seed Industry sued Bosheng Seed Industry for infringing on the technical secrets of "W68” and requested for an order of Bosheng Seed Industry assuming relevant infringement liabilities.
裁判结果
Result of Award
甘肃省兰州市中级人民法院一审认为，搏盛种业公司构成对“W68”技术秘密权益的侵害，判决其停止侵害，赔偿经济损失及维权合理开支共计150.5万元。搏盛种业公司不服，提起上诉，主张“W68”作为亲本不属于商业秘密的保护客体。最高人民法院二审认为，通过育种创新活动获得的具有商业价值的育种材料，在具备不为公众所知悉并采取相应保密措施等条件下，可以作为商业秘密依法获得法律保护。遂判决驳回上诉，维持原判。
The Intermediate People's Court of Lanzhou City, Gansu Province held in the first instance that Bosheng Seed Industry constituted an infringement on rights and interests of technical secrets of "W68” and ordered it to cease the infringement and pay compensation for economic losses and reasonable expenses for safeguarding rights in a total sum of CNY 1.505 million. Bosheng Seed Industry was dissatisfied and filed an appeal, alleging that "W68" as a parent was not a protection object of business secrets. The Supreme People's Court held in the second instance that, the breeding materials with business value obtained from breeding innovation activities could obtain legal protection by law as business secrets under the circumstances of being unknown to the general public, subject to appropriate confidentiality, or the like. It was therefore ordered to reject the appeal and uphold the original sentence.
典型意义
Typical Significance
本案是最高人民法院审理的第一起涉及育种材料的商业秘密案件。判决明确了杂交玉米植物新品种的亲本作为商业秘密的保护条件和保护路径，是人民法院综合运用植物新品种、专利、商业秘密等多种知识产权保护手段保护育种成果的积极探索，有利于激励育种原始创新、持续创新，构建多元化、立体式的育种成果综合法律保护体系。
The present case, as heard by the Supreme People's Court, is the first case of business secrets involving breeding materials. The judgment specifies the protection condition and protection path of the parent of new variety of hybrid maize plant as a business secret, which represents an active exploration of the people's court on protecting breeding achievements by comprehensively utilizing a plurality of intellectual property protection means, including new plant variety, patent and business secret, and is beneficial to inspire original and continuous innovation in breeding and construct a diversified and three-dimensional comprehensive legal protection system for breeding achievements.
（来源：中华人民共和国最高人民法院）
(Source: Supreme People's Court of the People's Republic of China)
集佳新闻：
集佳合伙人李春亚律师等应邀为中国邮政集团总部及分公司进行法律风控授课
Attorney LI Chunya, Unitalen Partner, and Others Invited to Give Legal Risk Control Lectures to Headquarters and Branches of China Post Group
北京市集佳律师事务所作为中国邮政集团有限公司总部的知识产权维权顾问单位，近日，集佳合伙人律师李春亚、资深律师李安迪应邀参加“2023年度邮政企业法律风控专业管理能力提升培训班”的授课。在现场分享及积极互动中，集佳律师详细介绍了《商标法》、《著作权法》等修改热点，并结合集佳代理的“金蝶”“OPPO”“周六福”“美丽俏佳人”“一品石”“广本”“乐心”等商标、著作权、字号权利冲突的典型案例，就各类商业标识的合规使用、权利冲突解决思路及维权策略作进行深入分享。
Beijing Unitalen Law Office is the intellectual property protection consultant of headquarters of China Post Group Corporation. Recently, Attorney LI Chunya, the Unitalen Partner, and Senior Attorney LI Andi were invited to give lectures in "Training Class on Professional Management Competence Improvement in Legal Risk Control for Postal Enterprises in 2023". During the on-site sharing and active interaction, the Unitalen attorneys delivered a particular introduction to amendment hotspots regarding the Trademark Law, the Copyright Law and the like, and in combination with typical cases of conflicts over trademark, copyright and trade name right represented by Unitalen, including "KINGDEE", "OPPO", "ZHOU LIU FU", "美丽俏佳人", "一品石", "HONDA" and "LIFESENSE", shared profoundly the compliant use of various business identifiers, ideas for resolving rights conflicts, and rights protection strategies.
.jpg)